The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127260751 12726075 1 I 2015 20160829 20160908 20160908 EXP ES-AGEMED-842936340 ES-MYLANLABS-2016M1036998 MYLAN 0.00 Y 0.00000 20160908 MD ES ES

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127260751 12726075 1 PS ESCITALOPRAM ESCITALOPRAM OXALATE 1 Oral 10 MG, QD 1270 MG Y U 77660 10 MG QD
127260751 12726075 2 I OMEPRAZOLE. OMEPRAZOLE 1 UNK 0
127260751 12726075 3 I TRAMADOL. TRAMADOL 1 UNK 0
127260751 12726075 4 I SECALIP FENOFIBRATE 1 UNK 0
127260751 12726075 5 I ALDOCUMAR WARFARIN SODIUM 1 Oral UNK Y U 0
127260751 12726075 6 I TRANGOREX AMIODARONE HYDROCHLORIDE 1 Oral 200 MG, QD 0 200 MG QD
127260751 12726075 7 I EFFERALGAN ACETAMINOPHEN 1 UNK 0
127260751 12726075 8 C NEBIVOLOL. NEBIVOLOL 1 0
127260751 12726075 9 C FUROSEMIDE. FUROSEMIDE 1 0
127260751 12726075 10 C AMLODIPINE AMLODIPINE BESYLATE 1 0
127260751 12726075 11 C METFORMIN HYDROCHLORIDE W/SITAGLIPTIN METFORMIN HYDROCHLORIDESITAGLIPTIN PHOSPHATE 1 0
127260751 12726075 12 C SALMETEROL/FLUTICASONPROPIONAAT SALMETEROL 1 0
127260751 12726075 13 C TIOTROPIUM TIOTROPIUM 1 0
127260751 12726075 14 C SALBUTAMOL ALBUTEROL 1 0
127260751 12726075 15 C LORMETAZEPAM LORMETAZEPAM 1 0
127260751 12726075 16 C METAMIZOLE METAMIZOLE 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127260751 12726075 1 Product used for unknown indication
127260751 12726075 2 Product used for unknown indication
127260751 12726075 3 Product used for unknown indication
127260751 12726075 4 Product used for unknown indication
127260751 12726075 5 Atrial fibrillation
127260751 12726075 6 Product used for unknown indication
127260751 12726075 7 Product used for unknown indication
127260751 12726075 8 Product used for unknown indication
127260751 12726075 9 Product used for unknown indication
127260751 12726075 10 Product used for unknown indication
127260751 12726075 11 Product used for unknown indication
127260751 12726075 12 Product used for unknown indication
127260751 12726075 13 Product used for unknown indication
127260751 12726075 14 Product used for unknown indication
127260751 12726075 15 Product used for unknown indication
127260751 12726075 16 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
127260751 12726075 LT
127260751 12726075 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
127260751 12726075 Drug interaction
127260751 12726075 Gastric ulcer
127260751 12726075 Haematocrit decreased
127260751 12726075 International normalised ratio increased
127260751 12726075 Upper gastrointestinal haemorrhage

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127260751 12726075 1 20150121 20150528 0
127260751 12726075 5 20150527 0
127260751 12726075 6 201502 0